Sort
21,281 grants matching “influenza”
BRC-BIO: Defining the metabolic and molecular responses of host-viral-fungal interactions
$423,366Kelly M Shepardson · University Of California - Merced · · FY2025 · BIO
Systems Biology Approach to Study Influenza Vaccine in Children with Autoimmunity
$423,289Maria Virginia Pascual · Baylor Research Institute · U19 · FY2013 · AI
Immunity in the Nose to inFLUENza: Correlates of Efficacy (INFLUENCE)
$423,247Ryan Thwaites · Imperial College Of Science, Technology And Medicine · UH2 · FY2024 · AI
Biology and infection of bats with novel bat influenza viruses
$423,172Wenjun Ma · Kansas State University · R01 · FY2018 · AI
Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy
$423,156William Nicholas Haining · Massachusetts General Hospital · U19 · FY2018 · AI
Determinants of H. influenzae Virulence in Otitis Media
$423,069Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2011 · DC
Examining the Effects of Immulina to Increase Immune Resilience against Influenza Virus Infections
$423,031Gailen D. Marshall · University Of Mississippi · U19 · FY2020 · AT
Coordinate Regulation of Bacterial Virulence Factors
$422,986Harvard University (Medical School) · R01 · FY2005 · AI
High-throughput experiments to guide influenza vaccine strain selection
$422,967Jesse D Bloom · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Training in Immunological Mechanisms
$422,882Michael Croft · La Jolla Institute For Immunology · T32 · FY2025 · AI
T Cell Memory
$422,756Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Maternal flu infection and brain development in primates
$422,652Christopher L. Coe · University Of Wisconsin-Madison · R01 · FY2007 · AI
NTHi Type IV pili: expression and vaccine potential
$422,598Robert S. Munson · Research Inst Nationwide Children'S Hosp · R01 · FY2007 · DC
NTHi Type IV pili: expression and vaccine potential
$422,593Robert S. Munson · Research Inst Nationwide Children'S Hosp · R01 · FY2010 · DC
Rapid structural characterization of most promising novel mAbs and vaccines
$422,592Andrew Barrett Ward · Vanderbilt University Medical Center · U19 · FY2019 · AI
Monitoring System For Vector-Based Influenza Vaccine
$422,582Matthew M. Ferris · Indevr, Inc. · R43 · FY2007 · AI
Molecular characterization of the influenza hemagglutinin mediated membrane fusion
$422,578Mahmoud Moradi · University Of Arkansas At Fayetteville · R15 · FY2020 · GM
Type I interferon-stimulated genes and the antiviral immune response
$422,500Charles M. Rice · Rockefeller University · R01 · FY2015 · AI
Malaria vaccines modified with TLR agonist adjuvant
$422,500Elizabeth H Nardin · New York University School Of Medicine · R56 · FY2010 · AI
Type I interferon-stimulated genes and the antiviral immune response
$422,500Charles M. Rice · Rockefeller University · R01 · FY2012 · AI
Type I interferon-stimulated genes and the antiviral immune response
$422,500Charles M. Rice · Rockefeller University · R01 · FY2011 · AI
Malaria vaccines modified with TLR agonist adjuvant
$422,500Elizabeth H Nardin · New York University School Of Medicine · R56 · FY2009 · AI
Type I interferon-stimulated genes and the antiviral immune response
$422,500Charles M. Rice · Rockefeller University · R01 · FY2014 · AI
P.falciparum var gene diversity and malaria control
$422,500Karen Patricia Day · New York University School Of Medicine · R01 · FY2010 · AI
Structural and mechanistic studies of self and non-self recognition by RIG-I
$422,467Gary Alan Brewer · Rutgers, The State Univ Of N.J. · R01 · FY2017 · GM